MarketPeel
Insider Trading Intelligence
Pricing
…
OG

Ori Gutwerg

ANIP
SVP, GENERICS · ANI PHARMACEUTICALS INC · CIK 0001846478
FILING MIX · LIFETIME33%/67%
BUYS
13
SELLS
27
TOTAL VALUE
$6.32M
COMPANIES
1
ACTIVE SINCE
Feb 2021
HOLDINGS NOW
78,696
AVG SELL PX
$60.83
TRADE KIND
SHOWING 40 / 40
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
9 backtested trades · 8 horizons · 12 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Ori Gutwerg, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d9+44.44%+0.92%-0.70%+1.75%-0.13%—
14d9+55.56%+0.62%-0.32%+0.51%-1.53%—
30d9+44.44%+2.08%-3.22%+5.30%+3.98%—
60d9+33.33%+3.30%-0.33%+3.63%+0.03%—
90d9(1 pending)+37.50%+2.00%+4.18%-2.34%-5.36%—
180d9(2 pending)+57.14%+17.77%+11.93%+5.84%-17.03%—
1y9(3 pending)+50.00%+11.23%+21.18%-9.95%-6.88%—
2y9(6 pending)+0.00%+32.53%+47.20%-14.67%-6.45%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ANIP · 78,696 shares · as of May 12, 2026
025,83551,67077,504103,33920222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 13 buys / 27 sellsCOVERAGE · 22 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ANIP
ANI PHARMACEUTICALS INC
SALE
SVP, GENERICS
2,772$79.50$220.4K78,696May 12, 2026May 13, 2026 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SVP, GENERICS
3,314$74.04$245.4K81,468Mar 7, 2026Mar 10, 2026 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SVP, GENERICS
2,060$76.50$157.6K84,782Mar 3, 2026Mar 4, 2026 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SVP, GENERICS
2,221$73.90$164.1K86,842Feb 28, 2026Mar 2, 2026 ↗View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
12,969$77.15$1.00M89,063Feb 26, 2026Mar 2, 2026 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SVP, GENERICS
1,888$77.36$146.1K76,094Feb 14, 2026Feb 17, 2026 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SVP, GENERICS
1,775$76.70$136.1K77,982Feb 12, 2026Feb 17, 2026 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SVP, GENERICS
4,267$76.25$325.4K79,757Feb 11, 2026Feb 13, 2026 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SVP, GENERICS
5,873$86.53$508.2K84,024Aug 12, 2025Aug 14, 2025 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SVP, GENERICS
881$60.07$52.9K89,897May 15, 2025May 16, 2025 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SVP, GENERICS
3,314$60.62$200.9K90,778Mar 7, 2025Mar 14, 2025 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SVP, GENERICS
300$60.03$18.0K99,176Mar 5, 2025Mar 7, 2025 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SVP, GENERICS
5,084$60.00$305.0K94,092Mar 5, 2025Mar 7, 2025 ↗View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASE
SVP, GENERICS
300$31.49$9.4K99,476Mar 5, 2025Mar 7, 2025 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SVP, GENERICS
300$31.49$9.4K13,204Mar 5, 2025Mar 7, 2025 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SVP, GENERICS
1,570$61.89$97.2K99,176Feb 28, 2025Mar 4, 2025 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SVP, GENERICS
1,167$58.92$68.8K100,746Feb 15, 2025Feb 18, 2025 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SVP, GENERICS
1,426$58.92$84.0K101,913Feb 14, 2025Feb 18, 2025 ↗View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
10,444——103,339Feb 12, 2025Feb 18, 2025 ↗View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
15,668——92,895Feb 12, 2025Feb 18, 2025 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SVP, GENERICS
2,985$67.00$200.0K77,227Jun 5, 2024Jun 6, 2024 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SVP, GENERICS
2,494$66.71$166.4K80,212Mar 7, 2024Mar 7, 2024 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SVP, GENERICS
1,570$67.67$106.2K82,706Feb 29, 2024Mar 1, 2024 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SVP, GENERICS
1,244$57.55$71.6K84,276Feb 15, 2024Feb 20, 2024 ↗View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
14,763——75,678Feb 14, 2024Feb 16, 2024 ↗View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
9,842——85,520Feb 14, 2024Feb 16, 2024 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SVP, GENERICS
13,502$31.49$425.2K13,504Aug 23, 2023Aug 25, 2023 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SVP, GENERICS
13,502$62.39$842.4K62,974Aug 23, 2023Aug 25, 2023 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SVP, GENERICS
2,059$62.39$128.5K60,915Aug 23, 2023Aug 25, 2023 ↗View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASE
SVP, GENERICS
13,502$31.49$425.2K76,476Aug 23, 2023Aug 25, 2023 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SVP, GENERICS
586$44.23$25.9K34,027Mar 7, 2023Mar 9, 2023 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SVP, GENERICS
1,756$44.23$77.7K34,613Mar 7, 2023Mar 9, 2023 ↗View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
11,578——62,974Feb 28, 2023Apr 4, 2023 ↗View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
17,369——51,396Feb 28, 2023Apr 4, 2023 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SVP, GENERICS
1,275$45.04$57.4K36,369Feb 15, 2023Feb 16, 2023 ↗View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
6,476——37,644Apr 27, 2022Apr 29, 2022 ↗View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
19,428——31,168Mar 24, 2022Mar 28, 2022 ↗View →
ANIP
ANI PHARMACEUTICALS INC
SALE
SVP, GENERICS
1,167$40.25$47.0K11,740Feb 15, 2022Feb 17, 2022 ↗View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
12,907——12,907Feb 15, 2021Feb 17, 2021 ↗View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
27,006——27,006Feb 15, 2021Feb 17, 2021 ↗View →
Other insiders · ANIP
Loading peer insiders…
About this filer
CIK 0001846478
ROLE
SVP, GENERICS
PRIMARY
ANIP
COMPANIES
1
ACTIVE SINCE
Feb 2021
MARKETPEEL · /INSIDER/0001846478DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback